Matthew Perrone is a Health Writer at the Associated Press. He covers the intersection of medicine, money, and public policy, focusing on topics such as the FDA, social issues, and alternative medicine. His work has been featured in prominent outlets including HuffPost, The Washington Post, and NBC News.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Matthew Perrone's coverage predominantly focuses on healthcare and pharmaceutical matters, particularly government announcements and regulatory issues related to prescription drugs, e-cigarettes, and medical products. Given this focus, experts in public health policy, pharmaceutical regulation, or healthcare law may find success in reaching out to him for commentary.
Pitches should be tailored to offer expert insights into the legal and regulatory aspects of pharmaceuticals or medical devices. Experts with knowledge of FDA regulations as well as those who can provide analysis on government actions related to healthcare would likely resonate with Matthew's coverage.
While he does not specify a geographic focus beyond his association with The Associated Press based in the United States (Tennessee), pitches should be relevant to U.S. national issues unless there is a specific tie-in that he has covered previously.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Matthew Perrone
The Food and Drug Administration is proposing a rule that cosmetic companies would have to take extra steps to ensure that any products containing talc are free of asbestos
WASHINGTON — Changes are coming to the cold and cough aisle of your local pharmacy: U.S. officials are moving to phase out the leading decongestant found in hundreds of over-the-counter
By: Matthew Perrone
The most popular nasal decongestant on U.S. pharmacy shelves may not be there much longer By MATTHEW PERRONE AP Health Writer
By: Matthew Perrone
WASHINGTON – Makers of medical devices that quickly measure oxygen levels in the blood would have to gather extra data to show that their products work for patients of color, under a new federal proposal released Monday.
By: Matthew Perrone
WASHINGTON (AP) — Makers of medical devices that quickly measure oxygen levels in the blood would have to gather extra data to show that their products work for patients of color, under a new federal proposal released Monday.
By: Matthew Perrone
WASHINGTON (AP) — Makers of medical devices that quickly measure oxygen levels in the blood would have to gather extra data to show that their products work for patients of color, under a new federal proposal released Monday.
By: Matthew Perrone
Federal health officials are proposing changes to make sure medical devices that measure oxygen levels are working for patients of color
Makers of medical devices that quickly measure oxygen levels in the blood would have to gather extra data to show that their products work for patients of color, under a new federal proposal released Monday. The Food and Drug Administration's recommendations apply to pulse...
By: Matthew Perrone
WASHINGTON — Makers of medical devices that quickly measure oxygen levels in the blood would have to gather extra data to show that their products work for patients of color, under a new federal proposal released Monday.
By: Matthew Perrone
Makers of medical devices that quickly measure oxygen levels in the blood would have to gather extra data to show that their products work for patients of color, under a
(833) 317-6278 
